LogicBio To Be Bought By Alexion, AstraZeneca Rare Disease
3/10 13:57
(RTTNews) - LogicBio Therapeutics, Inc. (LOGC), a company focused on gene delivery and editing platforms to treat rare diseases, said on Monday that it has inked a deal to be acquired by Alexion, AstraZeneca Rare Disease...